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Abstract
Background: Laser bio-stimulation is a well-established procedure in Medical Acupuncture. Nevertheless
there is still a confusion as to whether it works or the effect is just placebo. Although a plethora of
scientific papers published, showing positive clinical results, there is still a lack of objective scientific proofs
about the bio-stimulation effect of lasers used in Acupuncture. The objective of this work was to design
and build a body surface electrode and an amplifier for biopotential recording from acupuncture points,
considered here as small localized bio-sources (SLB). The design is aimed for studying SLB potentials
provoked by laser stimulus, in search for objective proofs of the bio-stimulation effect of lasers used in
Medical Acupuncture.
Methods: The active electrode presented features a new adjustable anchoring system and fractionation
of the biopotential amplifier between the electrode and the cabinet's location. The new adjustable
electrode anchoring system is designed to reduce the electrode-skin contact impedance, its variation and
motion artifacts. That is achieved by increasing the electrode-skin tension and decreasing its relative
movement. Additionally the sensing element provides local constant skin stretching thus eliminating the
contribution of the skin potential artifact. The electrode is attached to the skin by a double-sided adhesive
pad, where the sensing element is a stainless steel, 4 mm in diameter. The fractionation of the biopotential
amplifier is done by incorporating the amplifier's front-end op-amps at the electrodes, thus avoiding the
use of extra buffers. The biopotential amplifier features two selectable modes of operation: semi-AC-
mode with a -3 dB bandwidth of 0.32–1000 Hz and AC-mode with a bandwidth of 0.16–1000 Hz.
Results: The average measured DC electrode-skin contact impedance of the proposed electrode was 450
kΩ, with electrode tension of 0.3 kg/cm2 on an unprepared skin of the inner forearm. The peak-to-peak
noise voltage measured at the amplifier output, with input terminals connected to common, was 10 mVp-
p, or 2 µVp-p referred to the input. The common-mode rejection ratio of the amplifier was 96 dB at 50 Hz,
measured with imbalanced electrodes' impedances. The prototype was also tested practically and sample
records were obtained after a low intensity SLB laser stimulation. All measurements showed almost a
complete absence of 50 Hz interference, although no electrolyte gel or skin preparation was applied.
Conclusion: The results showed that the new active electrode presented significantly reduced the
electrode-skin impedance, its variation and motion artifact influences. This allowed SLB signals with
relatively high quality to be recorded without skin preparation. The design offers low noise and major
reduction in parts, size and power consumption. The active electrode specifications were found to be
better or at least comparable to those of other existing designs.
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Background
The non-invasive nature of laser bio-stimulation have
made lasers an attractive alternative in Medical Acupunc-
ture at the last 25 years. Unfortunately there is still a con-
fusion as to whether they work or their effect is just
placebo. Although a plethora of scientific papers pub-
lished, showing positive clinical results, there is still a lack
of objective scientific proofs about the bio-stimulation
effect of lasers used in Acupuncture. The objective of this
work was to design and built a body surface electrode and
an amplifier for biopotential recording from acupuncture
points. The latter are considered here as small localized
bio-sources (SLB). As discussed by other authors, SLB are
small area body regions with specific electrical, physiolog-
ical and anatomical properties (e.g. high density of gap
junctions, relatively low impedance etc.) [1-4]. They
appear to be highly sensitive to mechanical, thermal, elec-
trical or electromagnetic stimulation and are found to take
place from the epidermis (stratum granulosum) to a max-
imum depth of 2 cm [5-8].
The active electrode is aimed for studying SLB potentials
provoked by laser stimulus, in search for objective proofs
of the bio-stimulation effect of lasers used in Medical
Acupuncture.
Methods
Electrode design
The attempt to define the optimal parameters of the active
electrode was based on a set of preliminary measurements
performed in our laboratory. Anatomical, physiological
and electrical characteristics of the signal source were con-
sidered. The SLB AC signal level, after stimulation, varied
from subject to subject, but did not exceed 1 mV peak-to-
peak (p-p). Additionally SLB occasionally manifested a
high DC potential up to 200 mV, implying the use of dif-
ferential amplifier with optional DC coupling and wide
DC input range. The frequency band of the signal of inter-
est was found to be in the range 0–200 Hz. The prelimi-
nary experiments showed that SLB potentials were best
recorded with small pasteless electrodes although their
contact impedance depends strongly on sweat gland secre-
tion. The application of electrolytic gel resulted in signifi-
cant reduction of the SLB signal amplitude, probably due
to smoothing of the potential caused by saturation of the
epidermis with electrolyte. Moreover, potentials between
closely spaced SLB might be shortened by the application
of excessive gel or large surface electrodes. An additional
difficulty is that the SLB are often situated at convex or
concave body surface areas where large flat electrodes
could not be easily affixed. Skin abrasion with sandpaper
is also not recommended since it can cause skin irritation
and SLB potential changes. However, the use of small pas-
sive dry electrodes on an unprepared skin results in high
electrode-skin impedance, motion artifacts, high power-
line cable interference and noise. When the electrodes are
DC coupled to the amplifier, a motion induced interfering
signal appears at the amplifier input, mainly due to:
• Electrokinetic effect – the disturbance of the double
layer of charge at the electrode-skin interface causes varia-
tions of the DC polarization potential [9].
• Skin potential or skin stretch artifact – stretching of the
skin causes a change of the potential of the barrier layer
between the epidermis and the dermis [10].
• Variation in the electrode-skin contact resistance –
caused by the amplifier input bias current and the current
flowing due to the polarization potential.
The complex electrochemical interactions that take place
at the electrode-skin interface have been subject to much
study in order an equivalent electrical model to be devel-
oped [10-12]. The simple but adequate electrical model
used, is shown in Fig. 1, where Cd//Rd is the coupling
impedance of the double layer at the electrode-skin inter-
face, Ci//Ri is the amplifier input impedance, Rs is the min-
imum series contact resistance and Vpol  is the DC
polarization potential. Then the motion artifact signal at
the amplifier input can be expressed as
Vmot = ∆Vpol + ∆Vskin + (∆Rd + ∆Rs) (VPOL / Ri + ib)   (1)
where ∆Vskin is the skin stretch artifact and ib is the ampli-
fier input bias current. It was deduced that in order to keep
the resistive interfering component less than 10 µV when
DC coupling is employed and with both currents contrib-
uting equally to it, then ib<50 pA and Ri>1 GΩ [11]. If an
AC coupling is used then the resistive component of the
motion artifact is eliminated.
For dry electrodes the motion artifacts are mainly caused
by changes of the polarization potential and the contact
impedance due to the poor electrolyte layer at the elec-
trode-skin interface. Therefore a firm electrode-skin con-
tact is of primary importance. Thus a new adjustable
electrode anchoring system was designed for the purpose,
as shown in Fig. 2. Turning the electrode cap clockwise
pushes the sensing element against the skin. Thus elec-
trode-skin pressure is increased, leading to reduction of
the contact impedance and its variation. The electrode-
skin relative movement is also reduced, making the noise
contribution of the electrokinetic effect insignificant.
Additionally, the sensing element provides constant skin
stretching that lowers the contribution of the skin poten-
tial artifact. Turning the electrode cap counter-clockwise,
releases the spring, which pushes back the sensing ele-
ment, resulting in a lower electrode-skin pressure. Tita-
nium, stainless steel and aluminum were considered asBioMedical Engineering OnLine 2004, 3:25 http://www.biomedical-engineering-online.com/content/3/1/25
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electrode sensing materials. Stainless steel was chosen
because it is more commonly available than titanium and
preferable to aluminum, which has been shown to have
problems due to chemical response of its oxide to perspi-
ration [13]. The use of stainless steel electrode material
ensures low noise, minimal offset potentials and excellent
DC stability suitable for low-drift DC measurements [14].
The sensing element is a 4 mm diameter, selected accord-
ing to the average SLB size. Although the obtained contact
impedances with the prototype electrode were relatively
low for dry electrodes of that size, impedance matching at
the electrode site was still needed to cope with the power-
line cable interference.
Basic amplifier circuit
Electrodes with impedance matching at the sensing site
are referred to as active electrodes and have been designed
since 1960's [15-17]. The electronic part of these transduc-
ers mostly consists of a buffer amplifier, but some have
been designed to need only two lead connection wire
[18,19]. However, as the signal is not amplified, buffers
introduce significant noise and a low noise amplifier is
still needed at the front-end. In order to avoid this draw-
back we used a two-op-amp biopotential amplifier [20]
shown in Fig. 3, where op-amps A0 and A1 were integrated
at the electrodes (Fig. 4), instead of using extra buffers.
This resulted in lower noise and less parts, at the expense
of increased number of electrode leads. The amplifier is
based on the two-op-amp instrumentation amplifier
shown in Fig. 5. The output voltage of the basic two-op-
amp amplifier is
where Ad1(s) is the differential-mode (DM) gain and
Ac1(s) is the common-mode (CM) gain of op-amp A1. If
we take the usual definitions for the DM input signal,
Vd=(E1-E0), and for the CM input signal, Vc=(E1 + E0)/2,
then the output voltage can be also written as
U1(s) = Ad(s)Vd + Ac(s)Vc   (3)
It can be shown that the respective expressions for the DM
gain Ad(s), and the CM gain Ac(s), are given by
where ,  τ0 and τ1 are the
respective DM open loop gains, and the time constants of
the first poles of op-amps A0 and A1 (assumed to be inter-
nally compensated), and Ac1(s) is the CM gain of op-amp
Equivalent electrical model of the electrode-skin interface Figure 1
Equivalent electrical model of the electrode-skin interface.
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A1. It should be noted that the CM gain of op-amp A0 is
omitted from (4) and (5), since its influence on both
gains is insignificant.
Considering (4) and (5), then the common-mode rejec-
tion ratio CMRR(s) is
Assuming op-amps A0 and A1 are ideal then the only factor
contributing to the CMRR is the mismatching of the resis-
tors. Thus we can define a common-mode rejection ratio
for the resistors, CMRRR. By taking 1/Ad0(s) = Ac(s) = 0 in
(6) we obtain
Therefore CMRRR(s) approaches infinity if the relevant
impedances are chosen according to
If the condition in (8) is fulfilled and op-amps A0 and A1
are ideal, then (4) simplifies to
Considering (7), equation (6) can be written as
Dry active electrode with adjustable anchoring system Figure 2
Dry active electrode with adjustable anchoring system.
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where CMRRA1(s) is the CMRR of op-amp A1. Further if
we assume that Z1, R2, R3 and ZE have tolerance t, then
from (7) and (8) we can deduce that the worst case condi-
tion will be when Z1 = Z10(1-t), R2 = R20(1+t), R3 = R30(1-
t) and ZE = ZE0(1+t) where Z10, R20, R30, and ZE0, are the
respective nominal values. Equation (7) then can be writ-
ten as
where  . This means that large dif-
ferential gain is desirable since very small tolerance com-
ponents are expensive. Therefore, considering (11),
equation (10) can be written as
The CMRRA1 has the form
where ωr is the frequency where CMRRA1 has decreased by
3 dB and is usually between 100 Hz and 1 kHz. The open
loop gain Ad0(s), also decreases at higher frequencies with
a corner frequency ω0 = 1/τ0 which is usually lower than
ωr, if A0 and A1 are of the same type. Therefore the CMRR
is mainly determent at low frequency by the matching of
the resistors and the DM gain, and at high frequencies by
Schematic of the biopotential amplifier with active DC rejection/suppression Figure 3
Schematic of the biopotential amplifier with active DC rejection/suppression.
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the open loop response of op-amp A0, rather than its
CMRR. If we take the advantage of the fact implicit in
(10), and achieve
then theoretically the CMRR becomes infinite. In part this
can be achieved by the use of a capacitor and resistor in
parallel for the impedance Z1 (Fig. 3), and then trimming
R2. Thus the need of low-tolerance components is elimi-
nated. Therefore Z1(s) will have the form
It has been shown [20] that a good approximation for the
optimal value of the capacitor C1 is
where GBPA0 is the gain bandwidth product of op-am A0.
Trimming R2 is a good solution for achieving an ultra high
CMRR for demanding application, however it is not prac-
tical since the trimmer has to be incorporated in the elec-
trode. Alternatively, ZE  or R3  can be trimmed, which
however will alter also the amplifier DM gain. Consider-
ing equation (12) it can be shown that for application
with relatively high DM gain and proper op-amp selec-
tion, both trimming and compensation (C1) can be omit-
ted, without significantly degrading the CMRR. For
example, if the usual 1% tolerance resistors are used and
op-amps with CMRR of 100 dB and DM open loop gain
of 120 dB at 50 Hz, then for an amplifier with DM gain of
5000, a CMRR of 96 dB can be achieved without
trimming.
In the amplifier circuit shown in Fig. 3, ZE is replaced with
an active DC rejection/suppression circuit [20]. It includes
an integrator (A2, Ri, Ci) and two potential dividers (R6, R5
and R4, R3). The amplifier can operate in AC-mode or in
semi-AC-mode. The two modes are selectable by the
Simplified schematic of the biopotential amplifier with active electrodes Figure 4
Simplified schematic of the biopotential amplifier with active electrodes.
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switch S1: AC-mode with S1 open and semi-AC-mode with
S1 closed. In AC-mode the DC signals are rejected, where
in semi-AC-mode they are suppressed. If R6 = R6 *, R5 = R5
* and Ri = Ri *, then the respective expressions for the
equivalent impedance ZE(s) for the two modes are given
by
where  τi = RiCi is the time constant of the integrator,
 and τ2 are the respectively the DM open
loop gain and the time constant of the first pole of op-
amp A2. Whenever Ri>>R5 then k ≈ (R6/R5+1), which is
true with the time constants and voltage gains, typical in
biopotential recordings. For signals bellow the amplifier
high-pass cut-off frequency, ZE(s) decreases due to the
active DC rejection/suppression circuit. For DC signals
equation (8) is maximally imbalanced and thus
CMRRR(0)  ≈ A d(0). Since for biopotential amplifiers
Ad(0) is much lower than CMRRA1(0) and Ad0(0), there-
fore CMRR(0) ≈ Ad(0), which represents the worst case.
If we consider only the -3 dB bandwidth and assume that
op-amp A2 is ideal, then (17) and (18) simplify to
Therefore, in this case (9) can be written as
Schematic of the basic two-op-amp instrumentation amplifier Figure 5
Schematic of the basic two-op-amp instrumentation amplifier.
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which represents the mid band DM gain for both modes.
After substituting (17) and (18) in (9), it can be shown
that the respective DC differential gains for the two modes
are given by
where 2k is approximately the DC gain of the stopped
integrator (A2, Ri, Ci, Ri *, R5 *, R6 *) in semi-AC-mode.
Thus DC signals meet lower gain, in order to prevent sat-
uration from large electrode offsets or other high DC
potentials.
The active electrodes' input resistances RiE0 and RiE1, are
not equal due to the different closed loop gains of op-
amps A0 and A1, and can be expressed as
where RiA0 and RiA1 are the input resistances of op-amps A0
and A1. However, at higher frequencies, the electrodes'
input impedances are much lower and about the same
(assumed that A0 and A1 are of the same type), due to the
op-amps' input and additional stray capacitance, being in
parallel to the high op-amps' input resistance.
The output noise spectral density for the -3 dB bandwidth
is approximately the same for both modes and can be
written as
where en0, en1 and en2 are the respective voltage noises of
op-amps A0, A1 and A2.
Assuming E0 is connected to common (Fig. 3), then the
amplifier transfer function H(s) is given by
After substituting ZE(s) and Ad1(s) in (24), it can be shown
that H(s) has three poles and two zeros for both modes.
However, with the time constants and voltage gain used in
the current application, one pole almost coincides with
one zero. Therefore, H(s) can be approximated very well
by a transfer function with two poles and one zero. The
respective approximations for AC-mode and semi-AC-
mode are given by
The circuits described by the transfer functions HAC(s) and
HsAC(s) are stable because all the poles are situated in the
left half of the complex s-plane and there are no resonance
effects as the poles are on the real s-axis.
Practical amplifier circuit
The schematic of a multichannel amplifier with active
electrodes, built according to the design discussed is
shown in Fig. 6. Each channel amplifies the signal
between its input (E1...EN) and the reference input E0
(monopolar configuration). The output voltage of op-
amp A2 is equal to the DC input voltage, multiplied by the
ratio (R3 + R4)/R3 for both modes. The choice of the resis-
tor ratio (R3 + R4)/R3 is a trade-off between DC input range
and noise, since a low ratio enhances the noise contribu-
tion of op-amp A2. The ratio R4/R3 was chosen so that to
allow a DC input voltage range of ± 370 mV, without sat-
urating op-amp A2. The offset voltage at the amplifier out-
put (U1) is the input offset voltage of op-amp A2, times
the resistor ratio (R5 + R6)/R5. In case of high DM gain, the
output offset voltage would become unacceptably high.
Thus, op-amp A2 was selected for its ultra-low offset volt-
age of 1 µV, low noise and high CM input range to prevent
latch-up. Moreover A2 is a low input bias current type,
which allows the use of high value input resistances with-
out producing large offset voltages between its inputs. Op-
amp A0, was selected with a relatively high GBP, in order
to confine its influence on the CMRR at higher frequen-
cies. Combining high DM gain, with high GBP op-amps,
allowed Z1 to be implemented only with its active part R1,
as thus the CMRR at 50 Hz was not significantly degraded.
As shown in (23), the equivalent input noise is mainly
determent by the noise of op-amps A0 and A1. They were
implemented with the low-noise CMOS op-amp LMV751
in a SOT23-5 package.
Because of the large integrator's time constant, the ampli-
fier has a very slow response after overloads (≤ 10τi),
caused by large signal disturbances. Thus a deblocking cir-
cuit was added at the cabinet's location, for temporary
reduction of the time constant during overload [24]. It is
controlled by the output voltage U1 through the low pass
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filter (R13, C2). The filter output controls two threshold
triggers (A3, A4), which through D1,D2 control the MOS
transistor T1, acting like a switch. When the output signal
reaches its range limits (defined by R14, R15, R16), T1 opens
and the new reduced time constant τi* = (R7//R11)C2,
pulls the output signal to the zero level. This state is main-
tained for additional hundred milliseconds (R13C2) and
then is switched back to its original value.
The connection between the amplifier common and the
signal source is implemented by a driven right-leg (DRL)
circuit. The CM voltage at the output of A0 is reduced by a
factor equal to the DRL circuit gain (ADRL = 314 at 50 Hz),
which theoretically should give a 50 dB extra CMRR at 50
Hz. In addition, in case of a faulty op-amp, the DRL circuit
will limit the maximum patient current to a safe level of
50 µA.
Results
The contact impedance of the proposed electrode, meas-
ured and averaged over five subjects, and its calculated
model impedance are shown in Fig. 7. The values of the
model elements were determent to give the closest agree-
ment between the measured electrode-skin impedance
and that of the model. The values are: Rs = 300 Ω, Rd = 450
kΩ and Cd = 3 nF. The measuring technique is described
by Bergey et al. [21] and was performed five minutes after
the application of the electrodes to allow their impedance
to settle to a constant value [13]. The electrodes were
applied with moderate tension of 0.3 kg/cm2 on an unpre-
pared skin of the inner forearm. The impedance was lower
when higher tension was applied or when sweat was
present on the skin. The applied current density was 0.01
mA/cm2 and no current density impedance dependence
was observed [22]. The electrode-skin impedance showed
two-decade spread between different subjects, which was
also reported in other works [23].
Simulations of the amplifier circuit were carried out using
PSPICE. The op-amps used in the model were with gain-
bandwidth product (GBP) of 5 MHz, DM open loop gain
of 120 dB and CMRR of 100 dB. The integrator time con-
stant and the resistor ratios of the feedback loop were: τi =
RiCi  = 1, R4/R3  = 6 and R6/R5  = 700. The amplifier
frequency response plots, for both operating modes, are
shown in Fig. 8. In semi-AC-mode the high-pass response
Multichannel biopotential amplifier with active electrodes and DRL circuit Figure 6
Multichannel biopotential amplifier with active electrodes and DRL circuit.BioMedical Engineering OnLine 2004, 3:25 http://www.biomedical-engineering-online.com/content/3/1/25
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is with 1st order pole at 0.32 Hz and zero at 0.2 mHz. In
AC-mode the high-pass response is with 1st order pole at
0.16 Hz and zero at 0.16 µHz. The mid band DM gain is
the same for both modes. Simulations were also carried
out for the estimation of the power line interference due
to induced displacement currents into the electrode leads.
The increased stray capacitance between the power line
and the amplifier, caused by the increased number of elec-
trode leads, was taken into consideration in the simula-
tion model. The results showed that the interference
caused by the active electrode unshielded leads was
insignificant.
Table 1 shows the amplifier specifications, measured with
battery powered prototype and test equipment. All the
parameters were in close agreement with those of the
simulations. The peak-to-peak noise voltage measured at
the amplifier output, with input terminals connected to
common, was 10 mVp-p, or 2 µVp-p when referred to the
input. The CMRR of the amplifier was 96 dB at 50 Hz,
measured with imbalanced electrode impedances (∆Ze =
47 kΩ). The maximum measured CMRR with DRL and a
CM input signal of 4 Vp-p, was 126 dB at 50 Hz, where the
output signal level was approximately equal to the ampli-
fier output voltage noise.
The average electrode-skin contact and the calculated model impedance against frequency Figure 7
The average electrode-skin contact and the calculated model impedance against frequency. The plot shows also the minimum 
and the maximum data sets for five subjects.BioMedical Engineering OnLine 2004, 3:25 http://www.biomedical-engineering-online.com/content/3/1/25
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A plot of the amplifier frequency response Figure 8
A plot of the amplifier frequency response.BioMedical Engineering OnLine 2004, 3:25 http://www.biomedical-engineering-online.com/content/3/1/25
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A sample record from the practical application of the
active electrode, obtained after a low intensity SLB laser
stimulation, is shown in Fig. 9. The amplifier was battery
powered and optically isolated by linear optocouplers.
The bandwidth was limited to 200 Hz, by 6th order low
pass Bessel filter, and the signal was sampled with 1 kHz.
The electrodes were connected with a high-density
unshielded ribbon cable. One electrode (E1) was placed
on SLB TH-23, near the eyebrow, where the reference (E0)
was placed on the ear lobe. No electrolyte gel or skin prep-
aration was applied. The measurements were performed
in a typical laboratory room. All measurements showed
almost complete absence of 50 Hz interference. The noise
present in the signal is mainly compounded of artifacts
from eye movements, electromyographic signals, and
noise from the electrode-skin interface.
Discussion
The best solution for an active electrode would be to per-
form the entire analog signal processing at the electrode
site. This could be achieved with a custom made inte-
grated circuit, but the cost would be much higher. We
found a good alternative in using SMD technology and
integrating only the front-end of the amplifier into the
electrode.
The ultra high input resistance of the electrode is degraded
at higher frequencies by the op-amp's input capacitance in
parallel with the stray capacitance due to the electrode
Printed Circuit Board (PCB). Nevertheless, combining an
op-amp with low input capacitance and a proper PCB
design, allowed a relatively high input impedance to be
achieved at 50 Hz. That decreased the amplifier sensitivity
to high electrode-skin impedance imbalances, by reduc-
ing the transformation of the CM interference signal into
unwanted DM signal. Unfortunately, most data sheets do
not properly specify op-amp's input capacitance, neither
DM nor CM.
The active electrode presented is not suitable for applica-
tions requiring a low differential gain and large signal
bandwidth due to the decreasing CMRR at higher frequen-
cies, if not properly compensated. On the other hand,
below the high-pass cut-off frequency, the CMRR is
degraded by the active feedback circuit, and reaches its
minimum value for DC signals, equal to the DM gain. The
circuit can accept high value input filter resistances, which
will also limit the patient auxiliary current in case of fault
condition of op-amps A0 and A1. Because of the limited
electrode space, it is preferable that the front-end op-amps
feature internal electrostatic discharge protection circuitry,
rather than building an external one.
Table 1: Active electrode specifications
Parameter semi-AC-mode AC-mode
Bandwidth (-3 dB) 0.32–1000 Hz 0.16–1000 Hz
DC gain 3.22 ≈ 0
AC mid band gain 74 dB
Differential mode AC input range 0.005–1 mVp-p
Differential mode DC input range ± 370 mV
Common mode input range ± 2 V
Input noise current 1 pArms @ 0.1–200 Hz
Input bias current 1.5 pA
Input impedance, Active Electrode 320 MΩ @ 50 Hz (1000 GΩ //10 pF)
CMRR 96 dB @ 50 Hz
Output offset 0.7 mV
Input noise voltage 2 µVp-p (0.33 µVrms) @ 0.1–200 Hz
Power consumption 11 mW @ one channelBioMedical Engineering OnLine 2004, 3:25 http://www.biomedical-engineering-online.com/content/3/1/25
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Conclusions
The new electrode anchoring system significantly reduced
the electrode-skin impedance, its variation and motion
artifact influences. The proposed amplifier fractionation
resulted in lower noise and less parts. Moreover splitting
the amplifier between the electrodes and the cabinet's
location allowed the use of an automatic DC deblocking
system and mode switching. The prototype tests showed
that with the active electrode presented, SLB signals with
relatively high quality could be recorded without skin
preparation. The 50 Hz interference pickup by the elec-
trode leads was practically eliminated. Because high elec-
trode-skin impedances are tolerated, no electrolytic gel is
needed. This allows fast application of the electrodes,
minimizes patient discomfort and eliminates the risk of
infection.
With proper op-amps selection, the active electrode spec-
ifications were found to be better or at least comparable to
those of other existing designs. The design offers low noise
and major reduction in parts, size and power consump-
tion. It is currently used in studying laser provoked SLB
potentials and their propagation, aiming to gain a better
insight into the bio-stimulation effect of lasers in Medical
Acupuncture.
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Biopotential acquired in semi-AC-mode from SLB TH-23 after low intensity laser stimulation Figure 9
Biopotential acquired in semi-AC-mode from SLB TH-23 after low intensity laser stimulation.Publish with BioMed Central    and   every 
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